Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei.
Dance
D A
DA
Wuthiekanun
V
V
Chaowagul
W
W
Suputtamongkol
Y
Y
White
N J
NJ
D000658:Amoxicillin / Q000494:pharmacology* / Q000627:therapeutic use; D019980:Amoxicillin-Potassium Clavulanate Combination; D016957:Burkholderia pseudomallei / Q000187:drug effects* / Q000302:isolation & purification; D002442:Ceftazidime / Q000494:pharmacology* / Q000627:therapeutic use; D002969:Clavulanic Acids / Q000494:pharmacology* / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008554:Melioidosis / Q000188:drug therapy; D008826:Microbial Sensitivity Tests
D002969:Clavulanic Acids; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin; D002442:Ceftazidime